CO4750670A1 - ANTICICATRIZANTE CREAM BASED CONQUIOLINA - Google Patents

ANTICICATRIZANTE CREAM BASED CONQUIOLINA

Info

Publication number
CO4750670A1
CO4750670A1 CO96059595A CO96059595A CO4750670A1 CO 4750670 A1 CO4750670 A1 CO 4750670A1 CO 96059595 A CO96059595 A CO 96059595A CO 96059595 A CO96059595 A CO 96059595A CO 4750670 A1 CO4750670 A1 CO 4750670A1
Authority
CO
Colombia
Prior art keywords
added
composition
polyethylene glycol
methyl paraben
conquiolina
Prior art date
Application number
CO96059595A
Other languages
Spanish (es)
Inventor
Zuleta Marco Antonio Ramirez
Original Assignee
Zuleta Marco Antonio Ramirez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zuleta Marco Antonio Ramirez filed Critical Zuleta Marco Antonio Ramirez
Priority to CO96059595A priority Critical patent/CO4750670A1/en
Publication of CO4750670A1 publication Critical patent/CO4750670A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

Composición de una crema anticicatrizante CARACTERIZADAPORQUE contiene 10 gr de concha de nácar, cuyo principio activo es la Conquiolina, llamada también Conchin, Periostracum, Epidermis o Epicutícula; 25 gr de polietilenglicol 4000, 65 gr de polietilenglicol 400, 0,15 gr de metil-parabeno y 0,2 gr de fragancia lavanda. Proceso para la obtención de la composición de una crema anticicatrizante de la Reivindicación 1 CARACTERIZADO PORQUE a la conquiolina, la cual se obtiene de las conchas, se les agrega ácido cítrico a saturación durante uno o dos días; luego a la solución se le añade el metilparabeno para evitar la descomposición; luego de formarse la masa, se pulveriza en un mortero o molino; aparte se colocan los polietilenglicoles en una marmita de acero inoxidable y se funden a 75°C; a la mezcla anterior se le adiciona la primera parte con agitación, se deja enfriar un poco y se le agrega la fragancia, para posteriormente envasar.Composition of an anti-healing cream CARACTERIZADAPORQUE contains 10 gr of mother-of-pearl shell, whose active ingredient is Conquiolin, also called Conchin, Periostracum, Epidermis or Epicuticle; 25 g of polyethylene glycol 4000, 65 g of polyethylene glycol 400, 0.15 g of methyl paraben and 0.2 g of lavender fragrance. Process for obtaining the composition of an anti-healing cream of Claim 1, CHARACTERIZED BECAUSE concholine, which is obtained from the shells, is added citric acid at saturation for one or two days; then methyl paraben is added to the solution to prevent decomposition; after the mass is formed, it is pulverized in a mortar or mill; Separately, the polyethylene glycols are placed in a stainless steel kettle and melted at 75 ° C; To the previous mixture, the first part is added with stirring, it is allowed to cool a little and the fragrance is added, to be subsequently bottled.

CO96059595A 1996-11-13 1996-11-13 ANTICICATRIZANTE CREAM BASED CONQUIOLINA CO4750670A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO96059595A CO4750670A1 (en) 1996-11-13 1996-11-13 ANTICICATRIZANTE CREAM BASED CONQUIOLINA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO96059595A CO4750670A1 (en) 1996-11-13 1996-11-13 ANTICICATRIZANTE CREAM BASED CONQUIOLINA

Publications (1)

Publication Number Publication Date
CO4750670A1 true CO4750670A1 (en) 1999-03-31

Family

ID=40930137

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96059595A CO4750670A1 (en) 1996-11-13 1996-11-13 ANTICICATRIZANTE CREAM BASED CONQUIOLINA

Country Status (1)

Country Link
CO (1) CO4750670A1 (en)

Similar Documents

Publication Publication Date Title
UY27320A1 (en) NEW PHARMACEUTICAL COMPOSITIONS
IL114641A (en) Pharmaceutical compositions containing dispersible fluoxetine
FR2627696B1 (en) NEW GALENIC FORM OF FENOFIBRATE
NO20004721L (en) Effervescent formulations
DK0758248T3 (en) Formulations for factor IX
ES2058411T3 (en) SUBSTANCE FR 901228 AND ITS PREPARATION.
SE7611379L (en) ANTIHYPERTENSIVE AGENTS
LV10381A (en) Satisfaction of solid medical forms and solid medical forms
MY127908A (en) Improved pharmaceutical formulations.
GB2302505A (en) Stabilisation of photosensitive materials
HUP0203121A2 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
GR3003355T3 (en) Nicorandil-containing preparation for injection
ATE75395T1 (en) PHARMACEUTICAL AND DIETARY COMPOSITIONS CONTAINING LINOLENIC ACIDS FOR THE TREATMENT OF BENIGN PROSTATE HYPERTROPHY.
CO4750670A1 (en) ANTICICATRIZANTE CREAM BASED CONQUIOLINA
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
GB2346619B (en) Surfactants
JPS557246A (en) Foamable bath salt having improved storage stability
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
ATE266404T1 (en) A STABLE PHARMACEUTICAL FORMULATION CONTAINING TORSEMIDE MODIFICATION II
SE8004383L (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION AND PROCEDURE FOR ITS PREPARATION
GR68699B (en)
MY101266A (en) Pharmaceutical formulations
AR013202A1 (en) NON-WATER VACCINES
ES481109A1 (en) Extract of Stephania cepharantha, process for preparing it and its therapeutical use.
JPS5536454A (en) Novel immunosuppressive agent